| 查看: 1287 | 回复: 3 | ||
| 【悬赏金币】回答本帖问题，作者医学僧僧将赠送您 8 个金币 | ||
[求助]
投稿求助 已有1人参与
|
||
|
七月底投的BMC infectious diseases,一周后回信说有重复，建议修改后重投，8月14重投，8.27送审，今天收到被拒的稿件，第一个编辑拒的很干脆，提出的问题也很专业，第二个编辑认为还可以，需要修一修，主编直接给的拒绝，各位大神看看，改一改重投还有机会不？附部分原文 Dear Professor Zhao, Thank you for considering BMC Infectious Diseases for your manuscript.Peer review of your manuscript is now complete and, based on the reports, I am sorry to say that we cannot consider the manuscript for publication and are closing your file. The reviewers' reports are included at the end of this email. Please note that as BMC Infectious Diseases has a policy of open peer review, you will be able to see the names of the reviewers. I wish you every success with your research and hope that you will consider us again in the future. Best wishes, Mar Masiá, MD, PhD BMC Infectious Diseases https://bmcinfectdis.biomedcentral.com/ Editor Comments: Reviewer reports: Jesús Bermejo-Martín (Reviewer 1): This paper present a combined score formed by A,B and C to improve mortality prediction . This work present major flaws and defects in the design. - Relative novelty: The paper shows a very similar approach to that already published in PMID: 28958655, By the way, this paper is not cited iby the authors.? - A is a biomarker denoting severity in those infections of bacterial origin. The authors do not present any data on the bacterial or viral By the way, this paper is not cited iby the authors.? In definitive, The authors should address this drawback in the future.? Minor comments: Further details on how the authors constructed the combined scores should be provided in the methodology. Ito Akihiro (Reviewer 2): Reviewer comments I think that this study is interesting and significant, however, I think that there are some important points to be revised. 发自小木虫IOS客户端 |
回复此楼» 猜你喜欢
朋友圈看到的
已经有9人回复
-
能否退出参与的面上项目解除限项
已经有13人回复
-
让我中一个面上吧！
已经有16人回复
-
放榜前的不淡定
已经有17人回复
-
科研孤儿太难了
已经有19人回复
-
明天应该可查了！？
已经有4人回复
-
什么时候开奖？
已经有11人回复
-
范进中举一文的中心思想
已经有6人回复
-
建议基金发布提前给出明确的时间点
已经有14人回复
-
2026国自然函评费到账
已经有17人回复
2楼2019-09-30 09:06:20
3楼2019-09-30 09:07:48
4楼2019-09-30 10:12:23
20